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Abstract Exposure of human proliferative cells to subcytotoxic
stress triggers stress-induced premature senescence (SIPS)
which is characterized by many biomarkers of replicative senes-
cence. Proteomic comparison of replicative senescence and
stress-induced premature senescence indicates that, at the level
of protein expression, stress-induced premature senescence and
replicative senescence are di¡erent phenotypes sharing however
similarities. In this study, we identi¢ed 30 proteins showing
changes of expression level speci¢c or common to replicative
senescence and/or stress-induced premature senescence. These
changes a¡ect di¡erent cell functions, including energy metab-
olism, defense systems, maintenance of the redox potential, cell
morphology and transduction pathways.
) 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Human diploid ¢broblasts (HDFs), endothelial cells, mela-
nocytes, etc. exhibit a stress-induced prematurely senescent
(SIPS) phenotype after several days of exposure to subcyto-
toxic stress like UV-irradiation, hyperoxia, H2O2, tert-butyl-
hydroperoxide (t-BHP), ethanol, etc. (for reviews, see [1,2]).
Many biomarkers of replicative senescence (RS) are observed
in SIPS, including a senescence-like cell morphology, irrevers-
ible cell cycle arrest in G1/S, telomere shortening, senescence-
associated L-galactosidase (SA L-gal) activity, deletions of mi-
tochondrial DNA, etc. [3^5]. The level of transcript of many
genes is altered in senescent cells when compared to cells at
early cumulative population doublings (CPDs), as shown by
Northern blot [6], semi-quantitative RT-PCR [5], subtractive
hybridization [7], di¡erential display [8] or DNA microarray
[9]. Other techniques restricted to a limited set of genes under-
going expression changes in RS show similar changes of ex-
pression level in SIPS induced by hyperoxia, H2O2 or t-BHP
(for a review, see [2]). However, these studies do not consider
the weakness of the correlation between a level of transcripts
and the abundance of the corresponding proteins [10].
Successful proteomic studies include biological problems as
diverse as the comparison of protein expression in normal
human luminal and myoepithelial breast cells puri¢ed from
mammoplasties [11] and the identi¢cation of a new anti-pro-
liferative protein in capillary endothelial cells cultivated in
vitro [12]. As concerns RS, a recent proteomic analysis using
high resolution two-dimensional gel electrophoreses (2DGE)
and mass spectrometry (MS) reveals new biomakers of repli-
catively senescent rat embryo ¢broblasts [13]. Another study
compares several lines of conditionally immortalized rat em-
bryo ¢broblasts and identi¢es new proteins involved in growth
arrest [14]. Another multi-di¡erential proteomic study based
on high resolution 2DGE compares the proteomes of WI-38
fetal lung HDFs undergoing RS or SIPS induced by t-BHP or
ethanol [15]. This study shows di¡erences between RS and
SIPS at the level of protein expression. HDFs in SIPS display
di¡erences at the level of protein expression which are either
common with RS, speci¢c to the type of stress or to SIPS
(regardless of the type of the stress). The di¡erences at the
level of protein expression which are speci¢c to the types of
stress or to SIPS are de¢ned as ‘molecular scars’ of subcyto-
toxic stress [1].
In this work we identi¢ed as many as possible of the pro-
teins undergoing changes of expression level in RS and/or
SIPS. One-dimensional (1D) Western blot analyses were per-
formed to detect proteins for which several isoforms were
identi¢ed or suspected. Semi-quantitative real-time RT-PCRs
were undertaken to check whether di¡erences at the protein
level correlate with di¡erences of the level of the correspond-
ing transcript.
2. Materials and methods
2.1. Cell culture and induction of SIPS
WI-38 HDFs (American Type Culture Collection, Rockville, USA)
were routinely cultivated as previously described until RS [16]. The
medium+10% fetal calf serum (FCS) of slowly growing cultures was
changed every four days. Con£uent HDFs at early CPDs (under 60%
of their proliferative life span) were exposed ¢ve times for 1 h to 30
WM t-BHP (Merck, Darmstadt, Germany) or ¢ve times for 2 h to 5%
ethanol (v/v; Merck, Darmstadt, Germany). The stressors were di-
luted in culture medium+10% FCS, with one stress/day for ¢ve
days. After each stress, the HDFs were rinsed with PBS bu¡er and
incubated in culture medium+10% FCS.
2.2. Preparative 2DGE, protein extraction and MS for protein
identi¢cation
At 48 h after the last stress the HDFs were washed twice with
HBSS bu¡er and lysed with a 9.5 mol/l urea bu¡er (Pharmacia, Upp-
0014-5793 / 02 / $22.00 M 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
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sala, Sweden), 2% (w/v) Nonidet P-40 (Sigma, St. Louis, MO, USA),
5% (v/v) L-mercaptoethanol (Fluka, Buchs, Switzerland) and 2% (v/v)
ampholytes pH 7^9 bu¡er (Pharmacia, Uppsala, Sweden). Preparative
IEF and NEpHGE 2DGE were performed similarly to the analytical
ones, as described in [15]. The gels were loaded with 200 Wg/gel of
non-labelled sample mixed with a quantity of labelled sample corre-
sponding to 2W106 cpm. These gels were neither ¢xed nor ampli¢ed
before exposure to X-ray ¢lms (AGFA Curix RP2, Agfa-Gevaert,
Morsel, Belgium) for ¢ve days. Protein spots were excised from the
gel before in-gel tryptic digestion performed as previously [17]. The
resulting peptides were puri¢ed and concentrated on home-made
nano-scale reversed phase disposable columns prior to MS analysis.
The proteins were identi¢ed on the basis of their ‘peptide map’ [18]
acquired with a Bruker Re£ex II (Bruker Daltonics, Bremen, Ger-
many) matrix-assisted laser desorption/ionization (MALDI) instru-
ment. Peptide Search software was used to search the nrdb sequence
database. When a protein was not identi¢ed on the basis of its peptide
map, peptides of the protein were micro-sequenced using a Q-tof
instrument (Micromass, Manchester, UK). The sequence elements
obtained were used to perform a ‘peptide sequence tag’ search in
nrdb [19] or to carry out a BLAST search and compare the obtained
sequences against the available sequence databases.
2.3. 1D Western blot and semi-quantitative real-time RT-PCR analysis
Cell lysates for immunoblot were prepared in lysis bu¡er (SDS 2%,
glycerol 10%, DTT 50 mM, Bromophenol Blue 0.1% in Tris^HCl, pH
6.8, 62.5 mM) at 72 h after the last stress. Western blots were per-
formed as described [5]. We used anti-HSP27 (Biotech, Santa Cruz,
CA, USA), anti-Prx VI (kind gift of Dr. A.B. Fisher, Institute for
Environmental Medicine, University of Pennsylvania, Philadelphia,
PA, USA), anti-alpha-tubulin (Innogenex, San Ramon, CA, USA)
antibodies. The level of tubulin was used as reference level. Semi-
quanti¢cation was obtained with the ImageMaster TotalLab software
(Pharmacia, Uppsala, Sweden).
Total RNA was extracted (total RNA extraction kit, Promega,
Madison, USA) at 72 h after the last stress. mRNA was retrotran-
scribed, starting from 2 Wg total RNA (Superscript RII reverse tran-
scriptase, Invitrogen, Carlsbad, USA). The sequences of the primers
were determined (Primer Express 5.1 software, Applied Biosystems,
Foster City, CA, USA) (Table 1). cDNA and primers concentrations
were experimentally determined for the PCRs to remain in the expo-
nential zone of ampli¢cation for each gene. Real-time PCRs were
performed using SYBR Green as intercalating agent (ABI Prism
7000 instrument, Applied Biosystems). The conditions of PCR were
10 min at 95‡C, 40 cycles of 15 s at 95‡C and 1 min at 60‡C. The
steady-state level of the mRNA of the 23-kDA highly basic protein
was used as reference for semi-quanti¢cation with the vvCT method
[20]. The speci¢city of ampli¢cation was checked by performing a
dissociation curve (gradient from 60‡C to 95‡C) and electrophoresis
of the ampli¢cation products.
3. Results
The aim of this work was to identify as many as possible of
the proteins undergoing changes in expression level in RS and/
or SIPS. SIPS was induced by repeated subcytotoxic expo-
sures to t-BHP or ethanol [15]. The experimental conditions
were: HDFs at early CPDs (‘young’), senescent HDFs, HDFs
in SIPS induced by t-BHP or ethanol, and control HDFs.
Control HDFs were treated in the same conditions as the
stressed HDFs but were not exposed to the stressor. Six in-
dependent extracts of labelled proteins were prepared. Protein
labelling started at the ¢ftieth hour after the last stress, i.e.
when SIPS appeared. From each extract of proteins more
than 1800 protein species were visualized on 2DGE. Statistical
analysis revealed 50 spots with a signi¢cant di¡erence of in-
tegrated intensity (I.I.) between HDFs at early CPDs and
senescent HDFs. Thirty-eight changes were senescence-specif-
ic, whereas the 12 other changes were also found in SIPS
induced by t-BHP and/or ethanol. Thirteen and 25 spots
had di¡erent I.I. in SIPS induced by t-BHP and ethanol,
respectively, when compared to both HDFs at early CPDs
and control HDFs [15]. Fig. 1 summarizes these results and
a)
Phenotype Number of spots
with changed I.I.
Ratio of I.I.
(early CPDs=1)
RS increased I.I. :
decreased I.I. :
34
16
1.3 to 23.8
0.2 to 0.7
Total : 50
t-BHP-induced SIPS increased I.I. :
decreased I.I. :
11
  2
1.3 to 2.3
0.5 and 0.7
Total : 13
ethanol-induced SIPS increased I.I. :
decreased I.I. :
18
  7
1.3 to 2.5
0.5 to 0.7
Total : 25
b)
Senescent/Early CPDs
Total : 50 spots
t-BHP/Early CPDs
Total : 13 spots
Ethanol/Early CPDs
Total : 25 spots
38
0 6 6
6
1 7
Fig. 1. Summary of the results of the proteomic analysis comparing
RS and SIPS in WI-38 HDFs. a: Table presenting the number and
ratio of I.I. of spots with increased or decreased I.I. in RS when
compared to HDFs at early CPDs, and with increased or decreased
I.I. in SIPS induced by t-BHP and ethanol when compared to con-
trol HDFs+HDFs at early CPDs. Numbers in bold: total number
of changes found in each phenotype. b: Pattern of the number of
signi¢cant di¡erences in I.I. observed according to the experimental
conditions. The experimental conditions are senescent HDFs (com-
pared to HDFs at early CPDs), HDFs in SIPS induced by t-BHP
(compared to early CPDs+control HDFs) and HDFs in SIPS in-
duced by ethanol (compared to HDFs at early CPDs+control
HDFs).
Table 1
Sequences and melting temperatures (Tm) of the primers
Names Sequences Tm (‡C) Size amplicons (bp) Tm amplicons (‡C)
HSP27 forward TCCCTGGATGTCAACCACTTC 58 84 85
HSP27 reverse CTCGTGCTTGCCGGTGAT 59
Prx VI forward GGACGTGGCTCCCAACTTT 59 99 84
Prx VI reverse CGAGGGTGGGAGAAGAGAATG 60
23-kDa HBP forward GCCTACAAGAAAGTTTGCCTATCTG 60 134 82
23-kDa HBP reverse TGAGCTGTTTCTTCTTCCGGTAGT 60
Sizes and Tm of the sequences ampli¢ed by real-time PCR.
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gives the number of spots with di¡erent I.I. obtained in the
di¡erent experimental condition(s).
3.1. Protein identi¢cation
Preparative 2DGE and subsequent MS analyses led to the
identi¢cation of 30 proteins corresponding to spots selected in
the multi-di¡erential proteomic comparison described above.
These spots were pinpointed on 2DGE images (Fig. 2). Table
2 gives the names of the 30 proteins identi¢ed and their var-
iations of I.I. in the di¡erent experimental conditions. Nine of
the proteins identi¢ed were involved in the energy metabo-
lism. Seven of them were overexpressed in RS and/or SIPS.
Particularly, pyruvate kinase M 2 (PKM) was overexpressed
in RS and in SIPS induced by t-BHP or ethanol (spot N 101).
An increased PKM protein content in senescent HDFs could
explain the increase of the glycolytic activity and the subse-
quent higher production of lactate observed in these cells [21].
PKM is a key regulatory enzyme of glycolysis. Indeed, the
reaction it catalyzes is thermodynamically irreversible and fa-
vors an increase of the £ux of metabolites through glycolysis.
Pyruvate is produced by PKM and does not seem to be totally
consumed by the cycle of tricarboxylic acids in senescent
HDFs since lactate accumulates in these cells [21]. Another
enzyme involved in glycolysis, alpha-enolase (spots N 208 and
N 587), was among the proteins found to be overexpressed in
senescent HDFs. An increase in the amount of several key
glycolytic enzymes, among which PKM, was previously de-
scribed in the skeletal muscles of aged rats [22]. An increase
of the activity of glycolysis could counteract at least partially
the age-associated decrease in the mitochondrial capability
of ATP regeneration due to accumulation of damage in
the mitochondrial membranes and the mitochondrial DNA.
Along this line of evidence, the common 4977-bp deletion of
mitochondrial DNA was previously detected WI-38 HDFs,
whether in RS or t-BHP-induced SIPS [4]. Ethanol is known
to destabilize the biological membranes [23]. It also decreases
the respiratory activity of the mitochondria [24]. In addition,
pyruvate and D-glucose were found to be key survival factors
in various cell types exposed to a variety of stress at cytotoxic
doses. Pyruvate and D-glucose also protect WI-38 HDFs
against the appearance of the features of SIPS triggered by
exposures to subcytotoxic doses of t-BHP and ethanol (for
review, see [25]).
It is noteworthy that we observed a decrease of 35% in the
amount of glucose-6-phosphate-1-dehydrogenase (G6PDH;
spot I 342) in RS. A senescent-like phenotype has been ob-
served in HDFs de¢cient in G6PDH [26]. Textbooks of bio-
chemistry tell that a decrease in G6PDH content favors the
consumption of glucose-6-phosphate by glycolysis since it be-
comes less consumed by the pentose phosphate pathway. In-
deed G6PDH is the key regulator of the pentose phosphate
pathway, which is the main producer of cellular NADPH and
ribose-5-phosphate [27]. Glutathione reductase consumes
NADPH to reduce the thiol group of glutathione. A decrease
of 35% in G6PDH content could explain the decrease of the
concentration of reduced glutathione observed in senescent
HDFs [28]. Selenium-dependent glutathione peroxidase (Se-
GPx) oxidizes glutathione when detoxifying hydroperoxides.
Se-GPx is a major enzymatic component of the cellular anti-
oxidant system (for a review, see [29]). A shortage of NADPH
leads to a decrease of the activity of Se-GPx. This could
participate in the increase of the oxidant status taking place
during the in vitro ageing of HDFs [30]. Lastly, it is known
that ribose-5-phosphate is a precursor of the synthesis of the
bases of DNA. A shortage of these bases could be linked to
the growth arrest observed in RS.
Peroxiredoxin VI (Prx VI) has selenium-independent GPx
and phospholipase A2 activities [31]. Prx VI was identi¢ed on
our 2DGE in spots I 717, I 727 and I 818. These spots have
approximately the same molecular weight and have di¡erent
isoelectric points. Given that Prx VI has several putative phos-
phorylation sites [32], these spots could represent di¡erent
phosphorylated forms of this protein. Spot I 818 was the
most acidic spot and was more intense in SIPS induced by
t-BHP and ethanol, whereas its intensity decreased in RS.
Spot I 727 and I 717 were more intense in RS and in SIPS
induced by ethanol (Table 2), respectively. Western blots and
semi-quantitative real-time RT-PCRs were performed to
NEPHGE IEF
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Fig. 2. Typical 2DGE pattern obtained from WI-38 HDFs. For each of the 30 samples produced in this work, two types of gels were run:
IEF (from isoelectric point 3.5 to 7.0) and NEpHGE (from isoelectric point 6.5 to 11.0). The same 1819 spots were located on each of the 30
pairs of NEpHGE and IEF gels. The proteins present in the spots indicated by the arrows were identi¢ed by MS in this study. Their corre-
sponding changes in I.I. are given in Table 2.
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check whether the di¡erences in spot intensity would re£ect
di¡erences of the total amount of the protein and di¡erences
of the steady-state level of mRNA (Fig. 3). A good correla-
tion was found between the di¡erences of the steady-state
level of mRNA and total protein level of Prx VI in the di¡er-
ent experimental conditions. However, the total protein level
of Prx VI detected by Western blots (Fig. 3a) did not correlate
with the sum of the values of I.I. found for the three spots
identi¢ed as Prx VI (Fig. 4). The reason for these discrepan-
cies could be that one or several other isoforms of Prx VI were
not detected on the 2DGE, whereas they were detected by
Western blot. Fig. 4 indicates that the proportion between
the di¡erent isoforms of Prx VI identi¢ed in this study varied
between the di¡erent experimental conditions. We suggest
that such di¡erential post-translational modi¢cations could
in£uence the activity of this enzyme.
We identi¢ed two proteins with di¡erences of expression
level in SIPS induced by t-BHP and by ethanol and not in
RS. Firstly, the spots I 709 and I 1086 were identi¢ed as 14-3-3
tau protein. It has been shown previously that this protein can
block the cell cycle [33,34]. It could play a role in the cell cycle
arrest observed in SIPS [3,4]. Secondly, spot I 667 corre-
sponded to a 30^35-kDa isoform of actin. Fragments of actin
are known to play a role in the reorganization of the cytoskel-
eton in conditions generating stress ¢bers such as SIPS [35].
The isoform of actin identi¢ed in this work could participate
in the reorganization of actin into stress ¢bers observed in
SIPS [36]. These proteins could be considered as molecular
scars of the long-term e¡ects of subcytotoxic stresses [1].
Among the other proteins overexpressed in RS, we identi-
¢ed creatine kinase BC (spots I 500 and I 815) and HSP27
(spot I 684) (Table 2). It was found previously that the level of
their respective mRNAs is increased in replicatively senescent
HDFs and in skeletal muscle of aged mouse [9,37]. It is
known that HSP27 can be phosphorylated at di¡erent sites.
This could lead to the appearance of di¡erent spots on 2DGE
[38]. In this study Western blots showed that the level of
HSP27 was increased in replicatively senescent HDFs when
compared to HDFs at early CPDs. When compared to con-
trol HDFs (i.e. HDFs at early CPDs treated as the stressed
HDFs but not exposed to the stressor), HDFs in SIPS in-
duced by ethanol or t-BHP also contained a higher level of
HSP27 (Fig. 5a). In addition, we determined whether these
discrepancies existed between the level of protein and the level
of transcript of HSP27. Semi-quantitative real-time RT-PCRs
revealed an increase in the level of HSP27 mRNA in RS, and
in SIPS induced by t-BHP or in ethanol (Fig. 5). As proposed
for Prx VI, it could be that not all the isoforms of HSP27
have undergone changes in expression level that were detect-
able by 2DGE.
4. Discussion
We identi¢ed 30 proteins undergoing changes of expression
level in RS and/or SIPS. Some of the proteins identi¢ed sup-
port an increase in glycolytic activity, whereas other proteins
identi¢ed in this work can explain how a senescent(-like) phe-
notype appears. Western blots and 2DGE gave complemen-
Table 2
Proteins identi¢ed in the proteome analysis of RS and SIPS
Spot # Identi¢cation DB # MW pI Ratio RS Ratio t-BHP Ratio EtOH
N 101 pyruvate kinase M P14618 58 7.6 1.5X 0.3 1.7X 0.4 1.4X 0.2
I 818 PeroxiredoxinVI P30041 25 6.3 0.5X 0.1 1.4X 0.3 1.6X 0.4
I 709 14-3-3 protein tau P27348 28 4.7 new spot new spot
I 1086 14-3-3 protein tau P27348 28 4.7 new spot new spot
I 667 actin isoform (between 30 and 35 kDa) P53493 42 5.3 1.7X 0.5 2.5X 0.6
I 684 HSP27 P04792 24 7.8 1.3X 0.1
I 660 chloride intracellular channel protein 1 O00299 27 4.9 1.5X 0.2
N 472 electron transfer £avoprotein beta-subunit P38117 28 8.2 1.5X 0.2
I 734 BAG-family molecular chaperone regulator O95816 24 6.2 1.6X 0.2
N 389 alpha-actinin isoform (around 20 kDa) P12814 103 5.2 1.7X 0.7
I 727 Peroxiredoxin VI P30041 25 6.3 1.8X 0.3
N 628 lamin C P02546 65 6.8 1.9X 0.3
I 539 alcohol dehydrogenase P14550 36 6.3 2.0X 0.5
I 815 creatin kinase BC P12277 43 5.4 2.0X 0.6
I 500 creatin kinase BC P12277 43 5.4 2.1X 0.2
N 208 alpha-enolase P06733 47 7.4 2.0X 0.6
N 587 alpha-enolase P06733 47 7.4 5.5X 1.5
I 626 annexin 1 P04083 39 6.6 0.5X 0.2
N 623 calmodulin-binding protein O88482 67 11.3 0.6X 0.1
I 256 lamin C P02546 65 6.8 0.6X 0.2
N 464 NADH-cytochrome B5 reductase P00387 34 7.6 0.6X 0.3
I 412 actin P53493 42 5.3 0.6X 0.0
I 342 glucose-6-phosphate-1-dehydrogenase P11413 59 6.4 0.7X 0.1
I 717 Peroxiredoxin VI P30041 25 6.3 1.5X 0.3
N 102 pyruvate kinase M P14618 58 7.6 1.5X 0.2
I 610 esterase D P10768 31 7.0 1.4X 0.3
I 689 guanidinoacetate N methyltransferase Q14353 26 5.7 1.3X 0.1
I 1025 HSP90 P08238 83 4.8 0.6X 0.3
I 913 HSP90 P08238 83 4.8 0.7X 0.2
I 46 glucosidase II precursor Q14679 107 6.0 1.7X 0.3
Gel system with ‘N’ stands for NEpHGE and ‘I’ for IEF+spot number (spot #). SWISS-PROT or TrEMBL accession number (DB#), theoreti-
cal molecular weight in kDa (MW) and theoretical isoelectric point (pI) are given. The ratioX standard deviation of the I.I. of corresponding
spot between the di¡erent situations studied and HDFs at early CPDs is mentioned. ‘RS’ stands for replicatively senescent HDFs, ‘t-BHP’ for
HDFs in SIPS induced by t-BHP, and ‘EtOH’ for HDFs in SIPS induced by ethanol.
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tary information on the total level of Prx VI and HSP27 and
on the level of some of their various post-translationally
modi¢ed forms. Semi-quantitative real-time RT-PCRs were
also valuable for revealing post-transcriptional regulations.
The stress-induced changes of the level of expression of
speci¢c proteins appearing several days after stress, whenever
stress-speci¢c or common to several kinds of stress, can be
considered ‘molecular scars’ [1]. Molecular scars might also
occur in vitro and in vivo at several days or weeks after ex-
posure to di¡erent stressors like H2O2, UV, paraquat, ozone,
hyperoxia, in£ammation, ischemia-reperfusion, ethanol abuse,
etc. Finding some of the molecular scars appearing in these
conditions could help in understanding the pathophysiological
consequences of such conditions. Examples are the study of
gastric ulcer and leg venous insu⁄ciency where ¢broblasts
bearing several biomarkers of SIPS have been found [39].
Lastly, the combination of proteomics and SIPS in vitro rep-
resents a valuable toxicoproteomic tool for detecting the ef-
fects of subcytotoxic concentrations of molecules in RpD.
This kind of screening in vitro should be carried out before
in vivo testing. Indubitably this approach would decrease the
budgetary and ethical burden of in vivo toxicology.
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Fig. 4. Representation of the proportion of I.I. of the three di¡erent
spots (I 717, I 727 and I 818) corresponding to Prx VI identi¢ed in
the di¡erent experimental conditions. The I.I.s of each isoform have
been summed in each experimental condition.
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Fig. 5. a: Relative levels of HSP27 protein determined by Western
blot. Alpha-tubulin was used as reference for semi-quanti¢cation.
b: Relative levels of HSP27 transcripts determined by real-time
semi-quantitative RT-PCRs. The mRNA level of the 23-kDa HBP
was used as reference for semi-quanti¢cation. ‘Young’ stands for
HDFs at early CPDs, ‘RS’ for replicatively senescent HDFs,
‘t-BHP’ and ‘ethanol’ for HDFs in SIPS induced by t-BHP and
ethanol, respectively. ‘CTL’ are HDFs at early CPDs treated like
the stressed HDFs but with the stressor omitted.
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Fig. 3. a: Relative levels of Prx VI protein determined by Western
blots. Alpha-tubulin was used as reference for semi-quanti¢cation.
b: Relative levels of Prx VI transcripts determined by real-time
semi-quantitative RT-PCR. The mRNA level of 23-kDa HBP was
used as reference for semi-quanti¢cation. ‘Young’ stands for HDFs
at early CPDs, ‘RS’ for replicatively senescent HDFs, ‘t-BHP’ and
‘ethanol’ for HDFs in SIPS induced by t-BHP and ethanol, respec-
tively. ‘CTL’ are HDFs at early CPDs treated like the stressed
HDFs but with the stressor omitted.
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